Viewing StudyNCT00382798



Ignite Creation Date: 2024-05-05 @ 5:06 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00382798
Status: COMPLETED
Last Update Posted: 2009-04-27
First Post: 2006-09-28

Brief Title: Adaptive Phase I HCV Study With Nucleoside Analogue in Combination With Interferon and Ribavirin
Sponsor: Pharmasset
Organization: Pharmasset

Organization Data

Organization: Pharmasset
Class: INDUSTRY
Study ID: P7081-5101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pharmasset
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Amanda Beard
Old Organization: Pharmasset Inc

Collaborators

Name Class
Hoffmann-La Roche INDUSTRY